View in EDS

Author Correction: Trends in kinase drug discovery: targets, indications and inhibitor design.

Saved in:

Bibliographic Details
Title:	Author Correction: Trends in kinase drug discovery: targets, indications and inhibitor design.
Authors:	Attwood MM; Functional Pharmacology, Department of Neuroscience, Uppsala University, Uppsala, Sweden., Fabbro D; Cellestia Biotech, Basel, Switzerland., Sokolov AV; Functional Pharmacology, Department of Neuroscience, Uppsala University, Uppsala, Sweden., Knapp S; Structural Genomics Consortium, Goethe University Frankfurt, Buchmann Institute for Molecular Life Sciences, Frankfurt am Main, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer network DKTK and Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt am Main, Germany., Schiöth HB; Functional Pharmacology, Department of Neuroscience, Uppsala University, Uppsala, Sweden. helgi.schioth@neuro.uu.se.; Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia. helgi.schioth@neuro.uu.se.
Source:	Nature reviews. Drug discovery [Nat Rev Drug Discov] 2021 Oct; Vol. 20 (10), pp. 798.
Publication Type:	Published Erratum
Journal Info:	Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784 (Electronic) Linking ISSN: 14741776 NLM ISO Abbreviation: Nat Rev Drug Discov Subsets: MEDLINE; PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1474-1784
DOI:	10.1038/s41573-021-00303-4